Skip to main content
News > News > 业界巨擘进军可编程生物技术领域 | Open Therapeutics LLC on

业界巨擘进军可编程生物技术领域 | Open Therapeutics LLC on

老杳吧: 业界巨擘进军可编程生物技术领域

编译:Susan Hong

(参考原文:Intel, Microsoft, Autodesk Creating Life,by R. Colin Johnson)

Click here to read the Chinese article. 


Click here to read the Taiwanese reprint: 業界巨擘進軍可編程生物技術領域

Original EETimes article.

We Believe

Open Therapeutics crowdsources orphan and dormant therapeutic intellectual properties (IP) to scientists around the world. The goal is advancing research that ordinarily has not generated a public value or been recognized. This approach particularly helps underserved scientists to collaborate with their more financially capable colleagues.

How open science helps researchers succeed:

Open access, open data, open source, and other open scholarship practices are growing in popularity and necessity. However, widespread adoption of these practices has not yet been achieved. One reason is that researchers are uncertain about how sharing their work will affect their careers.

The review of the literature demonstrates that open science is associated with increases in citations, media attention, potential collaborators, job opportunities, and funding opportunities. These findings are evidence that open science practices bring significant benefits to researchers relative to more traditional closed practices.

Secured By miniOrange